That's quite an assumption that I'd say is 100% wrong. Can you name me one serious deal he's signed with a "legit" biotech? Did Lilly step up? No sir, it did not because it saw that what ever Koos found was of no significance worth pursuing. And why BPs don't buy patents without hard human clinical data to back it up. Why so many investors ignore that one nugget of truth is beyond me.
Of course you can't because he never has.
But I support anyone's right to wish and hope for something to actually happen because a blind squirrel occasionally finds a nut unless he gets run over by a car.
News 
Market Data 
Discover 
